Home

Flavia Borellini

CIK 1867426 · last filed 2026-07-13

Flavia Borellini is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for PLRX, was dated Jul 13, 2026. Current disclosed insider exposure totals $5.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.04M

Companies

4

Total Filings

12

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLRX Director — $1.07 — $0 1 2026-07-13
RVMD Director 26,215 $183.86 $4.82M $0 4 2026-06-23
RVMDW Director 25,024 $8.84 $221.2K $0 3 2025-06-30
Viracta Therapeutics, Inc. (VIRX) Delisted Director — $0.01 — $0 4 2024-06-24

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-13 PLRX Grant (A) — $0 EDGAR
2026-06-23 RVMD Grant (A) +1,191 $0 EDGAR
2025-06-30 RVMDW Grant (A) +3,142 $0 EDGAR
2024-06-28 RVMDW Grant (A) +4,248 $0 EDGAR
2024-06-24 RVMDW Grant (A) +4,800 $0 EDGAR
2024-06-24 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) — $0 EDGAR
2023-06-12 RVMD Grant (A) +5,200 $0 EDGAR
2023-06-09 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) — $0 EDGAR
2022-06-17 RVMD Grant (A) +5,200 $0 EDGAR
2022-06-10 Viracta Therapeutics, Inc. (VIRX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.